These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1261708)
1. Environmental factors in drug metabolism. Gillette JR Fed Proc; 1976 Apr; 35(5):1142-7. PubMed ID: 1261708 [TBL] [Abstract][Full Text] [Related]
2. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats. Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro biotransformation of theobromine by phenobarbital- and 3-methylcholanthrene-inducible cytochrome P-450 monooxygenases in rat liver. Role of thiol compounds. Shively CA; Vesell ES Drug Metab Dispos; 1987; 15(2):217-24. PubMed ID: 2882982 [TBL] [Abstract][Full Text] [Related]
4. [A selective decrease in cytochrome P450 in the liver microsomes of male rats following phenobarbital and 3-methylcholanthrene induction and acute tetrachloromethane poisoning]. Angelov EP Eksp Med Morfol; 1993; 31(3-4):1-15. PubMed ID: 7805614 [TBL] [Abstract][Full Text] [Related]
5. Hepatic drug metabolism and anesthesia. Poppers PJ Anaesthesist; 1980 Feb; 29(2):55-8. PubMed ID: 6990824 [TBL] [Abstract][Full Text] [Related]
6. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Ng SF; Waxman DJ Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156 [TBL] [Abstract][Full Text] [Related]
7. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854 [TBL] [Abstract][Full Text] [Related]
8. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents. Ng SF; Waxman DJ Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751 [TBL] [Abstract][Full Text] [Related]
9. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes. Wada O; Yano Y Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260 [No Abstract] [Full Text] [Related]
10. Xenobiotic metabolism and toxicity in primary monolayer cultures of hepatocytes. Holme JA NIPH Ann; 1985 Dec; 8(2):49-63. PubMed ID: 3908998 [TBL] [Abstract][Full Text] [Related]
11. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions. Fouts JR Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408 [No Abstract] [Full Text] [Related]
12. [Activity of the liver monooxygenase system after induction with phenobarbital in the early neonatal period]. Guliaeva LF; Mishin VM Vopr Med Khim; 1985; 31(5):49-53. PubMed ID: 3937330 [TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Campbell ME; Grant DM; Inaba T; Kalow W Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985 [TBL] [Abstract][Full Text] [Related]
15. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. You L Chem Biol Interact; 2004 Apr; 147(3):233-46. PubMed ID: 15135080 [TBL] [Abstract][Full Text] [Related]
16. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats. Kato Y; Kimura R Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies. Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345 [TBL] [Abstract][Full Text] [Related]
18. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537 [TBL] [Abstract][Full Text] [Related]
19. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds. Gillette JR Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860 [TBL] [Abstract][Full Text] [Related]
20. Induction of drug-metabolizing enzymes: mechanisms and consequences. Okey AB; Roberts EA; Harper PA; Denison MS Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]